SUBSCRIBE
SUBSCRIBE

Brandon May

Rafael Henrique/SOPA Images/LightRocket via Getty
Drug Development
Inovio Expects Late-Stage COVID-19 Vaccine Trial Data by Second Quarter
In a fourth quarter 2020 financial results announcement made on Monday, Inovio Pharmaceuticals said it has completed enrollment of 400 participants in its Phase II segment of the INNOVATE (INOVIO INO-4800 Vaccine Trial for Efficacy) Phase II/III trial.
March 2, 2021
 · 
3 min read
 · 
Brandon May
Pictured: FibroGen sign/Smith Collection/Gado/Gett
FDA
Last-Minute FDA Advisory Panel Puts a Kink in Approval Hopes for Anemia Drug Roxadustat
The U.S. FDA has decided to put together an advisory committee meeting of outside experts to review a New Drug Application for roxadustat, FibroGen and its partner AstraZeneca’s investigational anemia therapy.
March 2, 2021
 · 
2 min read
 · 
Brandon May
Rafael Henrique/SOPA Images/LightRocket via Getty
FDA
FDA Approves BridgeBio Affiliate’s Therapy for Rare Metabolic Disease
This approval marks the first treatment indicated for reducing mortality risk in patients with the rare disorder known as molybdenum cofactor deficiency (MoCD) Type A.
March 1, 2021
 · 
3 min read
 · 
Brandon May
Perceptive Advisors’ ARYA Sciences Acquisition IV Raises $130 Million in IPO
Perceptive Advisors’ fourth healthcare blank check company ARYA Sciences Acquisition IV announced it has raised up to $130 million through the offering of 13 million shares at $10.
February 26, 2021
 · 
2 min read
 · 
Brandon May
AbbVie_© AbbVie Inc. All rights reserved.
FDA
Humira Bags Another FDA Approval, This Time for Pediatric Ulcerative Colitis
The U.S. Food and Drug Administration has approved AbbVie’s biologic therapy HUMIRA® (adalimumab) as a treatment for moderate-to-severe active ulcerative colitis in children aged 5 years and older.
February 25, 2021
 · 
2 min read
 · 
Brandon May
Vitamin C Study Fails to Improve Sepsis Outcomes
A new study published in JAMA suggests that treatment with vitamin C, in addition to thiamine and hydrocortisone, does not improve treatment outcomes in hospitalized patients with sepsis.
February 25, 2021
 · 
3 min read
 · 
Brandon May
Doppler Technique Allows Researchers to “Peek” Into Cells, Identify Antibiotic-Resistant Pathogens
Scientists from Purdue University are using Doppler radar to “peek” into cells and monitor metabolic activity in real time, allowing them to test microbes, detect pathogens in different environments and identify potential treatments for antibiotic-resistant bacteria.
February 24, 2021
 · 
3 min read
 · 
Brandon May
Pictured: J&J sign/Cristina Arias/Getty Images
Drug Development
FDA Set to Make Final Decision on J&J’s One-Dose COVID-19 Vaccine
The date set by the FDA’s independent advisors for debating that decision is Friday, February 26.
February 24, 2021
 · 
2 min read
 · 
Brandon May
Business
GRAIL and Quest Seek to Advance Multi-Cancer Early Detection Blood Test
Cancer detection company GRAIL has entered into an agreement with Quest Diagnostics that sees Quest providing phlebotomy services to support GRAIL’s multi-cancer early detection blood test Galleri™.
February 23, 2021
 · 
3 min read
 · 
Brandon May
David L. Ryan/The Boston Globe via Getty Images
Pharm Country
Pfizer Accused of Holding Some Countries to “Ransom” Over COVID-19 Negotiations
Pfizer has been accused of bullying governments in Latin America over coronavirus disease 2019 (COVID-19) vaccine negotiations, a recent investigative article revealed.
February 23, 2021
 · 
3 min read
 · 
Brandon May
Grand Warszawski/Shutterstock
Drug Development
Amgen Submits Supplemental NDA for Mild-to-Moderate Psoriasis Drug Otezla
Otezla, an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4) directed for cyclic adenosine monophosphate (cAMP), may indirectly modulate inflammatory mediators in certain conditions, but the specific underlying mechanisms are not clearly understood.
February 22, 2021
 · 
2 min read
 · 
Brandon May
Sarah Silbiger/Getty Images
Drug Development
BrainStorm Receives Feedback on Potential BLA Submission for ALS Therapy
The U.S. Food and Drug Administration said that data from BrainStorm Cell Therapeutics’ ALS Phase III trial does not meet the threshold of substantial evidence needed to support a BLA for the company’s ALS NurOwn therapy.
February 22, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
Immunome Isolates Antibodies Capable of Neutralizing SARS-CoV-2 Variants
Shares in the company shot up 212.6% following the news it had isolated the potentially variant-neutralizing antibodies.
February 18, 2021
 · 
3 min read
 · 
Brandon May
Pavel Metluk/Shutterstock
Policy
Scientists Call on WHO, CDC for Immediate Action to Protect High-Risk Workers From COVID-19
An open letter from a group of academics is urging the Biden administration to implement updates to guidance and standards that will better protect high-risk workers from the novel coronavirus that causes coronavirus disease 2019 (COVID-19).
February 18, 2021
 · 
3 min read
 · 
Brandon May
Smith Collection/Gado/Getty Images
Business
Nektar Secures Collaborative Deal with SFJ to Advance Head and Neck Cancer Therapy
Nektar Therapeutics has entered into a financing and co-development collaboration with SFJ Pharmaceuticals which will advance the development of investigational CD122-preferential IL-2–pathway agonist bempegaldesleukin for head and neck cancer.
February 17, 2021
 · 
3 min read
 · 
Brandon May
Load More